For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

Imperial College London

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine.

Type
D - Journal article
Title of journal
AIDS
Article number
-
Volume number
25
Issue number
1
First page of article
65
ISSN of journal
1473-5571
Year of publication
2011
URL
-
Number of additional authors
9
Additional information

The author made a substantial contribution to carrying out the study (including acquisition of study data).

The author helped critique the output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
D - Infection, Immunology and Inflammation
Citation count
20
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-